| Literature DB >> 29092076 |
Marta Poyo Solanas1, Minye Zhan1, Maarten Vaessen1, Ruud Hortensius1, Tahnée Engelen1, Beatrice de Gelder1,2.
Abstract
In the natural world, faces are not isolated objects but are rather encountered in the context of the whole body. Previous work has studied the perception of combined faces and bodies using behavioural and electrophysiological measurements, but the neural correlates of emotional face-body perception still remain unexplored. Here, we combined happy and fearful faces and bodies to investigate the influence of body expressions on the neural processing of the face, the effect of emotional ambiguity between the two and the role of the amygdala in this process. Our functional magnetic resonance imaging analyses showed that the activity in motor, prefrontal and visual areas increases when facial expressions are presented together with bodies rather than in isolation, consistent with the notion that seeing body expressions triggers both emotional and action-related processes. In contrast, psychophysiological interaction analyses revealed that amygdala modulatory activity increases after the presentation of isolated faces when compared to combined faces and bodies. Furthermore, a facial expression combined with a congruent body enhanced both cortical activity and amygdala functional connectivity when compared to an incongruent face-body compound. Finally, the results showed that emotional body postures influence the processing of facial expressions, especially when the emotion conveyed by the body implies danger.Entities:
Keywords: amygdala; body; emotion; fMRI; face
Mesh:
Year: 2018 PMID: 29092076 PMCID: PMC5793719 DOI: 10.1093/scan/nsx130
Source DB: PubMed Journal: Soc Cogn Affect Neurosci ISSN: 1749-5016 Impact factor: 3.436
Fig. 1.Examples of the stimuli of the main conditions employed in the experiment (catch condition not included). From left to right, up to bottom: congruent happy face–body compound (CH); incongruent face–body compound with happy body (IH); isolated happy body (BH); incongruent face–body compound with fearful body (IF); congruent fear face–body compound (CF); isolated fearful body (BF); isolated happy face (FH); isolated fearful face (FF); face–body compound control (CC).
Fig. 2.Results of the group functional activation analyses (cluster size corrected, initial P-value of 0.05). (A) The two congruent face–body compound conditions (CH + CF) are compared with the two incongruent ones (IF + IH); (B) CH > CF: congruent happy compounds vs congruent fearful compounds; (C) CF > IH: congruent fear compounds vs incongruent compounds with happy bodies; (D) CH > IF: congruent happy compounds vs incongruent compounds with fearful bodies; (E) IH > FF: incongruent compounds with happy bodies vs isolated fearful faces; (F) IF > FH: incongruent compounds with fearful bodies vs isolated happy faces; (G) CH > FH: congruent happy compounds vs isolated happy faces; (H) CF > FF: congruent fear compounds vs isolated fearful faces.
Fig. 3.Results of the group PPI analyses for both the right and left amygdalae (cluster size corrected, initial P-value of 0.05). (A) The two congruent face–body compound conditions (CH + CF) are compared with the two incongruent ones (IF + IH); (B) CH > CF: congruent happy compounds vs congruent fearful compounds; (C) CF > IH: congruent fear compounds vs incongruent compounds with happy bodies; (D) CH > IF: congruent happy compounds vs incongruent compounds with fearful bodies; (E) IH > FF: incongruent compounds with happy bodies vs isolated fearful faces; (F) IF > FH: incongruent compounds with fearful bodies vs isolated happy faces; (G) CH > FH: congruent happy compounds vs isolated happy faces; (H) CF > FF: congruent fear compounds vs isolated fearful faces.